|
|
 |
|
Viewing report
|
|
|
|
Medicated Skin Care in Venezuela
Euromonitor International, April 2012, Pages: 30
Vaginal and topical antifungals represented a 72% share of medicated skin care value sales in 2011. Both have been two of the most dynamic categories in consumer health over the review period. Although innovation has been seriously limited in the entire industry due to regulatory constraints, Bayer launched a new format of its successful vaginal antifungal brand Gynocasten and also introduced a new topical antifungal named Canesfast. These categories benefit from large-scale advertising...
The Medicated Skin Care in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Medicated Skin Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
|
|
|
|
